Skip to main content
. 2020 Jul 21;9(15):e016262. doi: 10.1161/JAHA.119.016262

Table 3.

Meta‐Regression Analyses

Outcome Covariates
Age Male Sex BMI Diabetes Mellitus Baseline LDL
TC Z value −2.82 −0.95 2.30 −0.22 2.48
P value 0.005 0.343 0.021 0.822 0.013
LDL‐C Z value −4.41 −2.67 4.32 0.13 4.41
P value <0.001 0.007 <0.001 0.894 <0.001
Non–HDL‐C Z value −3.28 −1.51 2.62 0.08 3.00
P value 0.001 0.131 0.009 0.935 0.003
ApoB Z value −2.42 −1.13 2.12 0.32 2.01
P value 0.015 0.259 0.033 0.746 0.044
hs‐CRP Z value −3.23 −0.87 2.46 −0.96 2.56
P value 0.001 0.385 0.014 0.338 0.011

Impact of age, male sex, BMI, diabetes mellitus, and baseline LDL‐C on the difference in reduction of TC, LDL‐C, non–HDL‐C, ApoB, and hs‐CRP between patients receiving bempedoic acid and control treatment group. ApoB indicates apolipoprotein B; BMI, body mass index; HDL‐C, high‐density lipoprotein cholesterol; hs‐CRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein; LDL‐C, LDL cholesterol; and TC, total cholesterol.